Psychology & Psychiatry

New treatment for schizophrenia discovered

A research group led by professor Jesper Ekelund showed that by giving a very large dose of famotidine (200 mg daily), sufficient amounts of the drug are able to penetrate the so-called blood-brain barrier to affect the histamine ...

Cardiology

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Diseases, Conditions, Syndromes

Drug fails to help kidney transplant recipients

A drug that protects the kidneys of patients with chronic kidney disease does not seem to provide the same benefit to kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the ...

Oncology & Cancer

New target, new drug in breast cancer

Many breast cancers depend on hormones including estrogen or progesterone for their survival and proliferation. Eight years of lab work at the University of Colorado Cancer Center and elsewhere suggest that the androgen (AR) ...

Other

Animal blockade hitting British research: scientists

British scientists warned on Wednesday that research into debilitating diseases is under threat from a refusal by ferry operators and airlines to transport laboratory animals into the country.

Medical research

Opening the brain to new treatments

One of the trickiest parts of treating brain conditions is the blood brain barrier, a blockade of cells that prevent both harmful toxins and helpful pharmaceuticals from getting to the body's control center. But, a technique ...

Oncology & Cancer

A culprit behind brain tumor resistance to therapy

Persistent protein expression may explain why tumors return after therapy in glioblastoma patients, according to a study published on March 5th in the Journal of Experimental Medicine.

page 7 from 7